HIGH-LEVELS OF INTERLEUKIN-10 DURING THE INITIAL PHASE OF FULMINANT MENINGOCOCCAL SEPTIC SHOCK

被引:110
作者
DERKX, B
MARCHANT, A
GOLDMAN, M
BIJLMER, R
VANDEVENTER, S
机构
[1] EMMA KINDER ZIEKENHUIS,CHILDRENS ACAD MED CTR,DEPT PEDIAT INTENS CARE,1105 AZ AMSTERDAM,NETHERLANDS
[2] ACAD MED CTR,CTR HEMOSTASIS ATHEROSCLEROSIS & INFLAMMAT RES,AMSTERDAM,NETHERLANDS
[3] FREE UNIV BRUSSELS,HOP ERASME,DEPT IMMUNOL,B-1070 BRUSSELS,BELGIUM
关键词
D O I
10.1093/infdis/171.1.229
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin (IL)-10 has an important antiinflammatory effect by inhibiting endotoxin-induced production of proinflammatory cytokines, such as tumor necrosis factor-alpha and IL-1. Since both cytokines are produced in massive amounts during fulminant meningococcal septic shock and are associated with severity of disease, IL-10 was measured in plasma samples of 25 consecutive children with fulminant meningococcal septic shock shortly after admittance to a pediatric intensive care unit. High levels of IL-10 (median, 6021 pg/mL; range, 137-24,600) were found in surviving patients (median, 1268 pg/mL; range, 137-24,600) and in those who died (median, 9915 pg/mL; range, 3996-14,100). IL-10 levels correlated weakly (r = .38; P = .055) with severity of disease as measured by the Glasgow meningococcal septicemia prognostic score. The findings indicate that IL-10 is produced in massive amounts in the initial phase of fulminant meningococcal septic shock.
引用
收藏
页码:229 / 232
页数:4
相关论文
共 15 条
[1]   MACROPHAGE DEACTIVATION BY INTERLEUKIN-10 [J].
BOGDAN, C ;
VODOVOTZ, Y ;
NATHAN, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (06) :1549-1555
[2]   PLASMA ENDOTOXIN AS A PREDICTOR OF MULTIPLE ORGAN FAILURE AND DEATH IN SYSTEMIC MENINGOCOCCAL DISEASE [J].
BRANDTZAEG, P ;
KIERULF, P ;
GAUSTAD, P ;
SKULBERG, A ;
BRUUN, JN ;
HALVORSEN, S ;
SORENSEN, E .
JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (02) :195-204
[3]  
FIORENTINO DF, 1991, J IMMUNOL, V147, P3815
[4]   INTERLEUKIN-10 REDUCES THE RELEASE OF TUMOR-NECROSIS-FACTOR AND PREVENTS LETHALITY IN EXPERIMENTAL ENDOTOXEMIA [J].
GERARD, C ;
BRUYNS, C ;
MARCHANT, A ;
ABRAMOWICZ, D ;
VANDENABEELE, P ;
DELVAUX, A ;
FIERS, W ;
GOLDMAN, M ;
VELU, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) :547-550
[5]   INTERLEUKIN-10 PROTECTS MICE FROM LETHAL ENDOTOXEMIA [J].
HOWARD, M ;
MUCHAMUEL, T ;
ANDRADE, S ;
MENON, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (04) :1205-1208
[6]  
MALEFYT RD, 1991, J EXP MED, V174, P1209
[7]  
MALEFYT RD, 1993, J IMMUNOL, V151, P6370
[8]   INTERLEUKIN-10 PRODUCTION DURING SEPTICEMIA [J].
MARCHANT, A ;
DEVIERE, J ;
BYL, B ;
DEGROOTE, D ;
VINCENT, JL ;
GOLDMAN, M .
LANCET, 1994, 343 (8899) :707-708
[9]   INTERLEUKIN-10 CONTROLS INTERFERON-GAMMA AND TUMOR-NECROSIS-FACTOR PRODUCTION DURING EXPERIMENTAL ENDOTOXEMIA [J].
MARCHANT, A ;
BRUYNS, C ;
VANDENABEELE, P ;
DUCARME, M ;
GERARD, C ;
DELVAUX, A ;
DEGROOTE, D ;
ABRAMOWICZ, D ;
VELU, T ;
GOLDMAN, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (05) :1167-1171
[10]   INTERLEUKIN-10 INHIBITS THE INDUCTION OF MONOCYTE PROCOAGULANT ACTIVITY BY BACTERIAL LIPOPOLYSACCHARIDE [J].
PRADIER, O ;
GERARD, C ;
DELVAUX, A ;
LYBIN, M ;
ABRAMOWICZ, D ;
CAPEL, P ;
VELU, T ;
GOLDMAN, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (10) :2700-2703